First in Human Trial of MK4827, a Poly(ADP)ribose Polymerase (PARP) Inhibitor With Antitumor Activity in BRCA Mutation Carrier and Sporadic Cancer Patients
2013
Keywords:
- Correction
- Cite
- Save
- Machine Reading By IdeaReader
0
References
0
Citations
NaN
KQI